98%
921
2 minutes
20
Background: Incarcerated individuals have a disproportionate burden of cardiovascular risk factors. However, there is a paucity of data focusing on cardiovascular death and access to adequate health care among incarcerated individuals.
Methods: We used the Mortality in Correctional Institutions database from the US Bureau of Justice Statistics to examine cardiovascular deaths in all state prisons from 2001 to 2019, health care provision, as well as differences in these measures between racial and ethnic groups.
Results: From 2001 to 2019, there were a total of 18 227 (28.0% of total) cardiovascular deaths among those incarcerated in state prisons. After declining from 2001, age-standardized cardiovascular mortality rates increased since 2012, and were 128.2 per 100 000 in 2019. Most cardiovascular deaths (40.8%) occurred after ≥120 months of incarceration, with 24.4% developing the condition that caused death after incarceration. Approximately 19% of individuals were not medically evaluated, 31% did not receive any diagnostic testing, and 27% did not receive medications during their incarceration for the cardiovascular condition causing death. Compared with White counterparts, Black individuals who died while incarcerated had a higher proportion of death related to a cardiovascular cause (30.9% versus 27.8%, <0.001) and were less likely to be medically evaluated (78.6% versus 81.9%, <0.0001) or receive treatment during incarceration for the cardiovascular condition determined to be the cause of death (68.1% versus 72.6%, <0.0001).
Conclusions: Cardiovascular disease is an important cause of death among individuals incarcerated in state prisons. A large number of individuals who died from cardiovascular disease, did not receive medical treatment during their incarceration, with racial disparities in carceral care provision. Strategies to ensure quality and equitable cardiovascular care for this population are needed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/JAHA.125.040983 | DOI Listing |
Nutr Clin Pract
September 2025
Nutrition Department, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Background: Early diagnosis of malnutrition is essential for rapid decision-making regarding nutrition care to improve patient outcomes. We aimed to evaluate the prevalence of malnutrition using the Global Leadership Initiative on Malnutrition (GLIM) criteria and to assess the association of GLIM with 1-year mortality and length of hospital stay (LOS) in patients admitted to an emergency department (ED).
Methods: Prospective cohort study conducted in the ED of a university hospital.
Nutr Clin Pract
September 2025
Department of Pediatrics, Mercer University School of Medicine, Macon, Georgia, USA.
Background: The purpose of our study was to describe the time to full oral enteral feeding for extremely low birth weight (ELBW) infants in the neonatal intensive care unit (NICU).
Methods: We conducted a retrospective chart review of ELBW infants born at a regional medical center between July 1, 2021, and December 31, 2022. Infants who died or were transferred before discharge from the NICU were excluded from the study.
JPEN J Parenter Enteral Nutr
September 2025
Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.
Background: Intravenous lipid emulsions are a key component of parenteral nutrition, and their fatty acid compositions may influence immune responses and clinical outcomes.
Methods: This retrospective cohort study conducted from January 2020 to December 2022 compared clinical outcomes of hospitalized non-critical care patients receiving parenteral nutrition with either mixed oil or soybean oil lipid emulsions for at least 48 h. The primary outcome was a composite of the presence of pneumonia, urinary tract infection, or an intra-abdominal collection diagnosed within 14 days of initiating parenteral nutrition.
Expert Rev Pharmacoecon Outcomes Res
September 2025
Faculty of Sciences and Medical Sciences, Lebanese University, Hadath, Lebanon.
Objective: To identify the major barriers to and facilitators of implementing the Lebanese Health Economic Evaluation Guideline (LEEG) according to Lebanese stakeholders, supported by their insights..
Methods: We conducted a survey asking 16 key stakeholders to rate LEEG's importance, its necessity for Lebanon, and its applicability in decision-making, and Likert scale questions to rate barriers and facilitators.